Skip to main content
. Author manuscript; available in PMC: 2022 Apr 7.
Published in final edited form as: Adv Exp Med Biol. 2021;1322:115–138. doi: 10.1007/978-981-16-0267-2_5

Table 5.12.

Host-acting pathway

Drug Class Route Company Clinical trial phase ClinicalTrials.gov identifier
APG-1387 Apoptosis inducer IV Ascentage Pharma, PR China 1 NCT03585322
CRV-431 Cyclophilin inhibitor Oral [103] Hepion, USA (formerly ContraVir) 1 NCT03596697

IV intravenous